Tablet density uniformity
SPOTLIGHT: Bill Supplee at Natoli Engineering discusses the best ways to ensure tablet density uniformity in pharma products
30 September 2025Hot Topics
Product Profile
Product News – Autumn Edition
IPT highlights some of the most recent exciting advancements in pharmaceutical manufacturing
Product Profile, 30 September 2025
Natoli Engineering Introduces EZ Level Feeder Base Leveling System
9 May 2025 -- Missouri, US -- Natoli Engineering, the global leader in tablet compression tooling, is unveiling the EZ Level Feeder Base Leveling System, Part Number SU 2970. This innovative design eliminates long setup times, enhances accuracy and minimizes formulation loss, and increases production time. You will no longer need to settle for “close enough” or “good enough” when using this solution that is built with precision in mind.
Product Profile, 8 May 2025
CARBOGEN AMCIS Shanghai Site Awarded Drug Manufacturing License from Chinese NMPA
22 April 2025 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce that its Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s National Medical Products Administration (NMPA).
Product Profile, 21 April 2025
Central Research Laboratories: Single-Use Gamma Bags for Biopharma and Life Sciences Applications
25 March 2025 -- Minnesota, US -- Central Research Laboratories (CRL), a global leader in the remote-handling industry, is launching Single-Use Gamma Bags that have been designed to undergo gamma-sterilization procedures. CRL Single-Use Gamma Bags are an addition to the company’s Single-Use Beta Bag product line, which also includes the recently launched Single-Use Double Bags.
Product Profile, 25 March 2025
PR No2 enables quick and easy IR detection
A second edition of the LASER COMPONENTS Pyroelectric Receiver series is now available!
Product Profile, 11 March 2025Press Releases
Thermo Fisher Scientific Expands Gibco Bacto Portfolio
15 December 2025 -- Massachusetts, US -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco Bacto CD Supreme FPM Plus and Gibco Bacto CD Supreme Feed (2X), two next-generation chemically-defined formulations that expand the Gibco Bacto CD portfolio to enhance and simplify plasmid DNA and recombinant protein production using Escherichia coli (E. coli).
Press Releases, 15 December 2025
Chai Discovery Announces $130 Million Series B To Transform Molecular Discovery
15 December 2025 -- California, US -- Chai Discovery, the AI company that predicts and reprograms the interactions between biochemical molecules, today announced its $130 million Series B financing round co-led by Oak HC/FT and General Catalyst. This round of financing values the company at $1.3 billion.
Press Releases, 15 December 2025
Novartis breaks ground on flagship manufacturing hub in North Carolina
12 December 2025 -- New Jersey -- Novartis, a leading global innovative medicines company, broke ground yesterday on its more than 700,000-square-foot flagship manufacturing hub in North Carolina, moving rapidly to construct its recently announced investment in the state.
Press Releases, 12 December 2025
Neuraxpharm and mjn-neuro announce plans to launch EPISERAS
27 November 2025 -- Barcelona, Spain and Düsseldorf, Germany -- Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of CNS disorders, and mjn-neuro, a start-up that designs, manufactures and markets medical devices, today announce the upcoming launch of EPISERAS, a pioneering digital health solution designed to predict the risk of epileptic seizures in real time.
Press Releases, 27 November 2025
Mettler-Toledo Launches X3 Series to Transform Bulk Flow Inspection
24 November 2025 -- Royston, UK -- Mettler-Toledo Product Inspection has unveiled the new X3 Series of bulk flow x-ray inspection systems, designed to deliver class-leading physical contamination detection, precision waste reduction and simplified operation.
Press Releases, 24 November 2025Digital
Making sense of your scientific archive: how RAG helps biotechs do more with less
How is retrieval-augmented generation aiding smaller biotechs in collating and utilising disparate data systems?
Digital, 16 December 2025
Building fine-tuning capabilities for co-folding models in pharmaceutical research
What are co-folding models and how is their use transforming drug development?
Digital, 16 December 2025
The new risk equation: balancing safety, speed and innovation in digital pharma
How can pharma companies improve their digital systems while maintaining regulatory compliance, and ensure the two teams work together cohesively?
Digital, 16 December 2025
Designing tomorrow’s biologics: how AI is enabling de novo protein discovery
Artificial intelligence-powered de novo protein design is opening new pathways in biologics discovery, allowing researchers to create synthetic proteins beyond nature’s existing repertoire
Digital, 30 September 2025
AI and SaaS: reshaping business outcomes in pharma manufacturing
How is artificial intelligence, when delivered through software as a service platforms, unlocking real business outcomes for pharmaceutical manufacturers, from faster batch release and smarter investigations to smoother tech transfers and enterprise-wide compliance?
Digital, 30 September 2025Manufacturing
Semantic layering: the technology reshaping pharma data architecture
How is semantic layering technology addressing significant efficiency gaps, creating the infrastructure for more efficient manufacturing operations?
Sustainable and scalable approaches to peptide manufacturing
Process innovations provide opportunities to reduce environmental impact while improving efficiency and product quality
X-ray CT for tablets: a powerful non-destructive tool for tablet characterisation
How is X-ray CT being used to ensure quality in tabletting?
Clone selection as a strategic lever: balancing speed, quality and long-term viability in CLD
In biologics development, clone selection is not just a technical milestone, it’s a strategic decision with far-reaching clinical and commercial implications. How can thoughtful clone selection – integrated with developability and manufacturability assessments – accelerate speed to clinic while safeguarding long-term success?
Advancing complex SM process development using biocatalysis
Biocatalysis is enhancing complex molecule process development. By merging the power of enzymes with chemical synthesis, scientists and manufacturers are addressing long-standing challenges in stereoselectivity, route complexity and sustainability
Delivering precision at every stage: integrated API and sterile drug product services
SPOTLIGHT: How CARBOGEN AMCIS supports complex molecules and challenging formulations from early development to commercialisation
Why advanced contamination detection systems are essential for pharmaceutical manufacturing
What are eight compelling reasons why manufacturers should prioritise the use of advanced contamination detection systems in their operations?
Tablet density uniformity
SPOTLIGHT: Bill Supplee at Natoli Engineering discusses the best ways to ensure tablet density uniformity in pharma products
Pharma manufacturing: cooperation for sustainable change
Sustainability is top of the agenda for many pharmaceutical manufacturing companies. Which role do technology providers and their equipment play in reducing CO2 emissions
Synthetic DNA: breaking the bottleneck in genetic medicine manufacturing
Why is the use of synthetic DNA a better choice for emerging genetic medicines?
Innovative manufacturing techniques for gene therapies
What are some innovative techniques used for manufacturing gene therapies at a commercial scale?
Natoli – data collection tips for R&D presses
Tablet formulation development often uses small R&D tablet presses to optimise both the composition of the formulation and manufacturing process parameters. These types of machines have a wide variety of capabilities and may be either single station or small rotaries.
Expertise in fine chemicals, cholesterol/vitamin D manufacturing
CARBOGEN AMCIS’ Manchester, UK, site plays a crucial role in early-phase drug development, providing high-quality starting materials and building blocks across industries, including pharmaceuticals, cosmetics, electronics and dental applications.
World-class drug product capabilities: from formulation to commercialisation
Our expertise in drug product development encompasses a wide range of pharmaceutical services. From formulation design to commercial-scale manufacturing, we specialise in efficiently bringing your drug product to market while ensuring full compliance with regulatory standards. Our highly skilled team at our state-of-the-art facility in Saint-Beauzire, France, ensures that your drug product is manufactured with precision and meets the highest quality standards.
Drug substance: from bench to market
With a strong track record in complex chemistry, CARBOGEN AMCIS offers end-to-end drug substance solutions, from preclinical development to commercial supply.
Driving innovation with purpose: our vision, values and expertise
CARBOGEN AMCIS is a leading global contract development and manufacturing organisation (CDMO), trusted by pharmaceutical and biopharmaceutical companies worldwide. With over 40 years of expertise, the company offers an integrated suite of services across drug substance and drug product development, helping clients to bring life-changing therapies to market with precision and efficiency.
Lab Design
Drug discovery’s weakest link? Why synthesis is the critical bottleneck in the age of AI
How is artificial intelligence being utilised in labs to synthesise design and workloads?
Labs that think: how intelligent design is shaping the future of pharma R&D
How are emerging design principles like operational insight, molecular infrastructure and human-centred design reshaping safety, agility and performance across the life sciences landscape?
Advancing fluid management in labs with automated small-volume filling
How can the introduction of automation in fluid management systems improve biopharma manufacturing?
Designing for the next generation of pharma labs
How are modern pharma labs being designed with practicality and connectivity to ensure streamlined processes and happy staff?
Smarter labs, better discovery: how automation is evolving pharma R&D
How is the industry translating the potential of automated technologies into practical, flexible and scalable workflows that address the real-world challenges of modern laboratories, ensuring that innovation delivers measurable scientific and operational gains?
From legacy systems to sample automation: managing a successful transition to high-density cold samp
As the need for ultra-low temperature sample storage rises, many labs are stuck expanding outdated ‘freezer farms’ to meet demand. High-density automated cold storage offers a smarter, more efficient solution, but reaping the benefits depends on more than the technology itself – it requires thoughtful change management. How can companies approach change management to drive lasting adoption and maximise the value of automation?
Smart resource strategy: optimising lab assets in pharma
In an era of cost-conscious innovation, including tighter budgets, talent shortages and escalating regulatory demands, life sciences labs are under pressure to improve performance while managing budgets more wisely. By focusing on equipment utilisation and asset intelligence, labs can reduce downtime, avoid unnecessary purchases, optimise maintenance intervals and scale smarter – all without compromising quality or compliance
Robotic automation in the pharma lab
IPT talks to Roya Amini-Naieni at Trilobio about robotic automation in pharma research, the different applications of soft-and hardware, and how the field is likely to develop over the next five years
Automated labs: the future of drug R&D
IPT talks to David Fuller at Artificial Inc about how automated labs are revolutionising the pharma R&D space by connecting disparate systems, easing the burden of manual tasks on workers, and speeding up time-to-market with tools such as artificial intelligence
Rapid microbiological monitoring: transforming environmental monitoring in pharma manufacturing
Ensuring a manufacturing environment stays clear of bacteria and fungi is of utmost importance, especially when it comes to pharmaceuticals. How can this highly specialised monitoring be achieved in a fast, cost-effective manner?
One cannot leverage AI without a connected laboratory
A connected laboratory, where systems and devices communicate seamlessly, is the foundation to unlock AI’s full capabilities
The journey to full automation – for labs of all sizes
With the lab of the future becoming increasingly automated, how will this change workflows and how can the industry prepare for this?
Bridging the gap: Integrating legacy equipment for modular production
The pharmaceutical sector is characterised by intricate processes, stringent regulations and a constant demand for innovation. However, the industry's digital transformation is hindered by the prevalence of legacy machinery, which often poses compatibility challenges when deploying new technology. COPA-DATA explains the method of standardisation to remove the barriers of integration of legacy equipment in labs and production lines
Lab automation: the future of life sciences
'Increasing economic challenges like market vitality, product diversification and cost pressure lead to the need for faster process design' − and that is not to mention the shorter innovation cycles and increasing demand for small batch production. The module type package suite from COPA-DATA meets these needs
Automation holds the key to unlocking the Lab of the Future
Lab layouts, until the introduction of automation, had seen little change in decades. However, the increased usage of hardware and software lab automation has reduced repetitive manual tasks and drastically increased the walkaway time involved in experiments
Five Steps to Successful AI
Whether lab managers are enthusiastic or apprehensive, AI is coming to the lab. The key to building this advantage is not in the technology, but the approach. Successful adoption of AI requires a genuine, long-term commitment. IPT spoke to Bob Voelkner at LabVantage Solutions about the implications of AI for pharma, what it takes to succeed with this new technology and his five recommended steps for getting started
Discovery and Development
Closing the actionability gap: spatial cell sorting advances drug discovery & translational research
Mapping disease cells in tissue is essential, but extracting and analysing them is what advances drug discovery. Spatial cell sorting enables physical isolation of individual cells for comprehensive multi-omics profiling – bridging the gap between tissue visualisation and functional validation
Discovery and Development, 16 December 2025
From passive polymers to active platforms: the nanotech evolution of hydrogels
Nanotechnology has unlocked a new generation of hydrogels that can be tuned for specific clinical demands. From degradation kinetics to drug release and mechanical resilience, nanoscale control is transforming hydrogels from passive wound dressings into active, minimally invasive platforms for joint restoration, tissue regeneration and targeted therapeutics
Discovery and Development, 16 December 2025
ssDNA: a novel approach to overcome efficacy and immunogenicity challenges in genetic medicines
What is single-stranded DNA and why is it a viable viral vector alternative?
Discovery and Development, 30 September 2025
The increasing pivotal role of predictive in vitro technologies in drug discovery
How will innovative human-centred in vitro testing strategies contribute to accelerating the delivery of safer and more effective therapies to patients without, or with minimal, use of animal models?
Discovery and Development, 30 September 2025
Viral clearance in advanced therapies
Should viral clearance studies be required for genetically engineered viral vectors and viral vector-derived products?
Discovery and Development, 30 September 2025Imaging and Sensing
How imaging flow cytometry is transforming cell and protein therapy
Advancements in imaging flow cytometry have improved the detection of particles in pharmaceutical formulations and helped provide insights into how these protein-based therapeutics work
Imaging & Sensing, 16 December 2025
Analytics for a new therapeutic era: meeting the demands of modern biologics
As novel biologics reshape the therapeutic landscape, more advanced analytics are essential. Single-particle technologies can help fill this gap, delivering faster, clearer insights and supporting the next generation of advanced therapies
Imaging & Sensing, 30 September 2025
LVEM: a new tool for AAV gene therapy and pharmaceutical development
How is low voltage electron microscopy revolutionising the electron microscopy landscape – making the practice more accessible in pharma labs?
Imaging & Sensing, 30 September 2025
Lessons learned from sequencing: a smart beginning for meaningful results
Massive sequencing, or next-generation sequencing, has opened the door to the fascinating world of genetics, and the secret on how to use this powerful tool most effectively hinges on the starting point: the sample
Imaging & Sensing, 30 September 2025
Transforming R&D workflows with automated super-resolution microscopy
What is super-resolution microscopy and how is it accelerating progress across the imaging sector?
Imaging & Sensing, 30 September 2025
Register now for mmc2025 incorporating EMAG 2025
1-3 July 2025, Manchester, UK
Imaging & Sensing, 17 June 2025Conferences and Events
BIO-Europe 2025
10 July 2025 -- Vienna, Austria -- BIO-Europe, Europe's premier biopharma partnering event, is heading to Vienna, Austria on November 3-5, 2025, followed by Digital Partnering on November 11-12.
Conferences and Events , 9 July 2025
Two Weeks to Go - LBS 2025 Spotlights Industry Pioneers, Disruptive Tech, Emerging Innovators
2 June 2025 — London, UK — In just two weeks, the second edition of the London Biotechnology Show (LBS) returns to ExCeL London on 18–19 June, bringing together one of the most influential gatherings in the global biotechnology calendar. The event promises cutting-edge science, transformative innovation, and forward-thinking leadership.
Conferences and Events , 1 June 2025
Attend Europe’s leading vaccine event!
World Vaccine Congress Europe will host 2500+ attendees, 280 speakers, 150 exhibitors and start-ups over the course of 4 days. With a multitude of tracks, the congress will cover everything vaccine related from start-to-finish from 13-16 October 2025.
Conferences and Events , 26 May 2025
Asia Bio Partnering Forum 2025
Join global biotech and pharma leaders in Singapore, September 9–10, 2025, for the third edition of Asia Bio Partnering Forum.
Conferences and Events , 22 May 2025
Chemspec Europe 2025 to deliver strong insights at a pivotal time for the chemicals industry
22 May 2025 -- Koelnmesse, Germany -- From 4–5 June, the international fine and speciality chemicals industry will gather at Koelnmesse, Germany, for the 38th edition of Chemspec Europe – the sector’s leading sourcing hub for chemical innovation in pharma and industry. Set in vibrant Cologne, near some of Europe’s largest chemical parks and pharma sites, the event provides a perfect gateway to connect with international professionals in chemical development and manufacturing.
Conferences and Events , 21 May 2025IPT TV
Inside the 2024 American Biomanufacturing Summit
Inside the 2024 American Biomanufacturing Summit
IPT TV, 3 June 2025
Visitor Registration at the London Biotechnology Show 2025 is Live!
Join the UK’s leading biotechnology event to explore groundbreaking biotech innovations, connect with global healthcare leaders, and discover the future of life sciences for 𝐅𝐑𝐄𝐄.
IPT TV, 21 April 2025
⭐We're proud to be a BioFIT 2024 partner!
Come and join us for the 13th edition of BioFIT, on December 3rd & 4th, 2024 in Lille and digital meetings days on December 11th & 12th, 2024!
IPT TV, 9 October 2024
LSX Nordic Congress 2024
Showcasing innovation, accelerating investment and facilitating partnering for life science leaders in Northern Europe.
IPT TV, 8 September 2024
TIDES Europe: Oligonucleotide & Peptide Therapeutics
Accelerate Your Therapeutics to Market: Expedite R&D, Improve CMC Efficiency & Build New Partnerships Join the industry’s leading event in Europe and access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies -- from discovery to market.
IPT TV, 4 September 2024
Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.